Application of rhenium-188 HEDP in bone metastases therapy
- PMID: 14600935
Application of rhenium-188 HEDP in bone metastases therapy
Abstract
Radionuclide bone metastases therapy is a major achievement of nuclear medicine. Development of less radiotoxic and more effective radiopharmaceuticals is therefore a challenge for radiopharmacists and industry. This paper reviews the application of rhenium-188 HEDP as a reactor- or generator-produced nuclide for bone metastases therapy.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical